Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • jaaker
    Junior Member
    • Aug 2012
    • 2

    #1

    MACS: output of MACS as an control file?

    I have three sets of data: immature wild-type cells, mature wild-type cells and mature knockout cells. We ran the knockout cells to control for any off target binding of our antibody for ChIP-seq. I have ran MACS to subtract out my mature knockout cells from my mature wild-type cells. Using any of those output files, can I subtract out those peaks/summits/areas/sequences from the immature wild-type cells? We think there is more important information in the immature wild-type cells but want to remove off-target binding (mature knockout cells) and changes during development (mature wild-type cells).

    I would like to run this in MACS:
    Treatment: Immature wild-type cells
    Input: (Mature wild-type cells minus mature Knockout cells)
    e.g. (Immature - (Mature WT - mature KO))

    Or do I need to perform some other option once I have the BED files from the MACS output?

    Thanks!
    -Josh

    Popko Lab
    University of Chicago

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Today, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
22 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
15 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
68 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Working...